ASPIRA WOMENS HEA.    NEW
ASPIRA WOMENS HEA. NEW
Share · US04537Y2081 · AWH · A3EDH3 (XNCM)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - -0,36 % -57,08 % -89,58 % -96,21 % -99,88 %

Company Profile for ASPIRA WOMENS HEA. NEW Share

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

Company Data

Name ASPIRA WOMENS HEA. NEW
Company Aspira Women's Health Inc.
Symbol AWH
Website https://aspirawh.com
Primary Exchange XNCM Frankfurt
WKN A3EDH3
ISIN US04537Y2081
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Ms. Nicolette Possemato
Country United States of America
Currency EUR
Employees 0,1 T
Address Building III, 78738 Austin
IPO Date 2000-10-02
Dividends from 'ASPIRA WOMENS HEA. NEW'
Ex-Date Dividend per Share
16.12.2016 0,02 USD
16.09.2016 0,02 USD
17.06.2016 0,02 USD
18.03.2016 0,02 USD
18.12.2015 0,02 USD
18.09.2015 0,02 USD
19.06.2015 0,02 USD
20.03.2015 0,02 USD
19.12.2014 0,02 USD
19.09.2014 0,02 USD

ID Changes

Date From To
27.01.2010 VRMLQ AWH

Ticker Symbols

Name Symbol
Frankfurt CUL.F
NASDAQ AWH

More Shares

Investors who ASPIRA WOMENS HEA. NEW hold also have the following shares in their portfolio:
DZ BANK      IS.A2849
DZ BANK IS.A2849 Bond
SEI Institutional Managed Trust Tax-Managed Volatility Fund Class F
SEI Institutional Managed Trust Tax-Managed Volatility Fund Class F Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025